Federal officials have charged 18 people in a wide-ranging series of COVID fraud cases.
The defendants are accused of taking part in a variety of schemes to exploit healthcare services during the pandemic, and allegedly led to more than $490 million in COVID-19 related false billings to and theft from federally funded pandemic programs, the Department of Justice (DOJ) said in a Thursday (April 20) news release.
“Exploiting the COVID-19 pandemic and viewing the public health emergency as an opportunity to steal money and resources from federal health care programs shows a clear disregard for the well-being and safety of those who rely on government-funded health care services,” said Inspector General Christi A. Grimm of the Department of Health and Human Services Office of Inspector General (HHS-OIG).
“As today’s enforcement action demonstrates, HHS-OIG and our partners remain steadfast in our commitment to protecting critical public health measures from fraud.”
Read more: DOJ’s Kanter Tests Positive For Covid After ‘Antitrust Day’
According to the release, the prosecutions include “first-of-their-kind” charges against suppliers of COVID-19 over-the-counter tests.
These defendants are accused of exploiting the government’s free test kit program and repeatedly supplying patients — or in some cases, patients who had died — with dozens of tests they didn’t want or need.
Among the other people charged were a California lab owner accused of submitting more than $358 million in bogus insurance claims. The DOJ says the lab performed legitimate COVID screening for nursing homes and schools, but also added claims for additional unwanted or unneeded testing to increase its reimbursements.
Also in California, a doctor is accused of defrauding the government’s uninsured program for $230 million, billing for services that were never performed or weren’t medically necessary. This doctor was the second highest biller in the program, the DOJ said.
The charges come weeks after the White House announced it was seeking congressional approval for a $1.6 billion plan to deal with COVID-related fraud.
The proposal would prosecute people who committed fraud related to the government’s pandemic relief funds, while also establishing protections for identity theft victims.
Featured News
Ribera Calls for Reform in EU Competition Policies
Dec 10, 2024 by
CPI
DirecTV Urges Second Circuit to Revive Antitrust Lawsuit Against Nexstar
Dec 9, 2024 by
CPI
Omnicom and Interpublic Unite in $13.25B Deal: Big Tech Competition Heats Up
Dec 9, 2024 by
CPI
Federal Ruling Highlights DOJ’s Push Against Algorithmic Collusion in Antitrust Cases
Dec 9, 2024 by
CPI
Judge’s Decision on Kroger-Albertsons Merger Expected Soon
Dec 9, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead